Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Gerber

Showing results (161-170 of 289) with videos related to

Pageof 29
Sort By:
Clinical Lung Cancer|September 20, 2024
Identification and Treatment of Lung Cancer Oncogenic Drivers in a Diverse Safety Net SettingKalyani Narra, Bassam Ghabach, Vivek Athipatla, et al.
JTO Clinical and Research Reports|March 19, 2026
Immune Checkpoint Inhibitor Outcomes in NSCLC Across Populations and Practice SettingsMatthew Lee, Jialing Liu, Kari J Teigen, et al.
Journal of Oncology Practice|September 15, 2016
Resolving Rivalries and Realigning Goals: Challenges of Clinical and Research Multiteam SystemsDavid E Gerber, Torsten Reimer, Erin L Williams, et al.
Breast Cancer Research and Treatment|February 23, 2021
Survival of women diagnosed with breast cancer and who have survived a previous cancerSandi L Pruitt, Hong Zhu, Daniel F Heitjan, et al.
Cancer|September 11, 2019
Type and case volume of health care facility influences survival and surgery selection in cases with early-stage non-small cell lung cancerShidan Wang, Sunny Lai, Mitchell S von Itzstein, et al.
Clinical Lung Cancer|December 8, 2016
Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non-Small-Cell Lung Cancer (RTOG 3505)David E Gerber, James J Urbanic, Corey Langer, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2023
Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignanciesAlexis C Boulter, Barry J Maurer, Meredith Pogue, et al.
British Journal of Cancer|November 1, 2018
Immune dysregulation in cancer patients developing immune-related adverse eventsShaheen Khan, Saad A Khan, Xin Luo, et al.
Journal of the American College of Radiology : JACR|October 4, 2025
Radiologists' Perceptions of the 21st Century Cures ActJessica H Porembka, Emily L Paton, Yin Xi, et al.
Cancer Medicine|June 30, 2021
Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancerSandi L Pruitt, David E Gerber, Hong Zhu, et al.
Pageof 29

Showing results (161-170 of 289) with videos related to

Sort By:
Pageof 29
Clinical Lung Cancer|September 20, 2024
Identification and Treatment of Lung Cancer Oncogenic Drivers in a Diverse Safety Net SettingKalyani Narra, Bassam Ghabach, Vivek Athipatla, et al.
JTO Clinical and Research Reports|March 19, 2026
Immune Checkpoint Inhibitor Outcomes in NSCLC Across Populations and Practice SettingsMatthew Lee, Jialing Liu, Kari J Teigen, et al.
Journal of Oncology Practice|September 15, 2016
Resolving Rivalries and Realigning Goals: Challenges of Clinical and Research Multiteam SystemsDavid E Gerber, Torsten Reimer, Erin L Williams, et al.
Breast Cancer Research and Treatment|February 23, 2021
Survival of women diagnosed with breast cancer and who have survived a previous cancerSandi L Pruitt, Hong Zhu, Daniel F Heitjan, et al.
Cancer|September 11, 2019
Type and case volume of health care facility influences survival and surgery selection in cases with early-stage non-small cell lung cancerShidan Wang, Sunny Lai, Mitchell S von Itzstein, et al.
Clinical Lung Cancer|December 8, 2016
Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non-Small-Cell Lung Cancer (RTOG 3505)David E Gerber, James J Urbanic, Corey Langer, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2023
Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignanciesAlexis C Boulter, Barry J Maurer, Meredith Pogue, et al.
British Journal of Cancer|November 1, 2018
Immune dysregulation in cancer patients developing immune-related adverse eventsShaheen Khan, Saad A Khan, Xin Luo, et al.
Journal of the American College of Radiology : JACR|October 4, 2025
Radiologists' Perceptions of the 21st Century Cures ActJessica H Porembka, Emily L Paton, Yin Xi, et al.
Cancer Medicine|June 30, 2021
Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancerSandi L Pruitt, David E Gerber, Hong Zhu, et al.
Pageof 29